Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life
Not applicable · Testing Nurse-led Telehealth Monitoring Program and No intervention · 1 site · Istanbul University - Cerrahpasa
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Nurse-led Telehealth Monitoring Program (a behavioral program) and No intervention as supportive care (to help with symptoms or quality of life). Condition(s) listed: Inflammatory Bowel Disease (IBD), Medication Compliance and Quality of Life.
Participants are assigned to groups by chance (randomized).
It is single-blind: participants do not know which group they are in.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Individuals aged 18 years or older
- Individuals aged 18 years or older
- Able to read and write in Turkish
Plus 6 more requirement(s). There are also 5 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 120 participants are expected to take part.
- Start date: 2024-04-20.
- Main results expected around 2024-07-20 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Turkey (Türkiye).
Main thing being measured
- Change in Medication Adherence Report Scale (MARS) scores (Baseline (Week 0) and 12 weeks (3 months) following telehealth monitoring.)
In the researchers’ words
This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Disease (IBD); Medication Compliance; Quality of Life; Telehealth Monitoring |
| Lead sponsor | Istanbul University - Cerrahpasa |
| Enrollment | 120 (estimated) |
| Start date | 2024-04-20 |
| Primary completion (est.) | 2024-07-20 |
| First posted | 2025-05-14 |
| Last updated | 2025-05-14 |
| Official title | The Effect of Telehealth Monitoring on Medication Compliance, Self-Efficacy and Quality of Life in Patients With İnflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT06971627 |
Interventions
- Nurse-led Telehealth Monitoring Program (Behavioral)
Participants in the intervention group will be included in a structured telehealth monitoring program led by a nurse for 12 weeks. - No intervention (Other)
Participants in the control group will only receive standard care. No additional interventions will be implemented during the 12-week period.
Full eligibility criteria (from the record)
Inclusion Criteria: * Individuals aged 18 years or older * Individuals aged 18 years or older * Able to read and write in Turkish * Diagnosed with inflammatory bowel disease (IBD) for at least 6 months * In clinical remission (Harvey-Bradshaw Index score < 5 or Simple Clinical Colitis Activity Index score < 3) * Able to use a smartphone * Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address * Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom) * Willing to participate in the study voluntarily Exclusion Criteria: * Diagnosed with any psychiatric or cognitive disorder * Having any condition that impairs communication * Pregnant women * Patients receiving infusion-based treatment * Having an advanced chronic disease
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology | Istanbul | Turkey (Türkiye) | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.